Arcus Capital Partners LLC Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Arcus Capital Partners LLC increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,113 shares of the company’s stock after purchasing an additional 119 shares during the period. Arcus Capital Partners LLC’s holdings in GE HealthCare Technologies were worth $322,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. CWM LLC boosted its position in GE HealthCare Technologies by 5.0% during the third quarter. CWM LLC now owns 11,186 shares of the company’s stock valued at $1,050,000 after buying an additional 531 shares during the period. Exchange Traded Concepts LLC boosted its holdings in GE HealthCare Technologies by 1.7% during the 3rd quarter. Exchange Traded Concepts LLC now owns 10,676 shares of the company’s stock valued at $1,002,000 after acquiring an additional 175 shares during the period. Swedbank AB grew its position in GE HealthCare Technologies by 6.6% during the 3rd quarter. Swedbank AB now owns 72,013 shares of the company’s stock worth $6,758,000 after acquiring an additional 4,490 shares during the last quarter. Vontobel Holding Ltd. increased its stake in GE HealthCare Technologies by 71.0% in the 3rd quarter. Vontobel Holding Ltd. now owns 41,294 shares of the company’s stock worth $3,875,000 after purchasing an additional 17,145 shares during the period. Finally, Seven Grand Managers LLC lifted its position in GE HealthCare Technologies by 150.0% in the third quarter. Seven Grand Managers LLC now owns 250,000 shares of the company’s stock valued at $23,462,000 after purchasing an additional 150,000 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the stock. Citigroup raised their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.31.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $93.48 on Friday. The stock has a market cap of $42.71 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 2.93 and a beta of 1.15. The business’s fifty day moving average is $83.81 and its 200 day moving average is $85.44. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. Research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.15%. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.